arrow
C

Christos Mikropoulos

Royal Surrey County Hospital
H指数:20
被引数:1,514

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer

LDR BURST试验:一项随机对照试验,比较使用间隔凝胶治疗的低剂量率近距离放疗与极超分次放疗在剑桥预后分组1-3的前列腺癌男性患者中的副作用

2026-04-270
PRE
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening

BARCODE1试点: 使用种系单核苷酸多态性靶向前列腺癌筛查的可行性研究

2021-08-1525
OAAI
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Imact研究的中期结果: BRCA2突变携带者前列腺特异性抗原筛查的证据

2019-12-01163
OAAI
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY)

成人高危致病性TP53突变携带者全身MRI筛查的社会心理影响: 病例对照研究 (SIGNIFY)

2019-11-1222
OAAI
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018)
2018-03-062
OAAI
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

在具有遗传易感性的男性的前瞻性前列腺癌筛查研究中,前列腺特异性抗原的速度

2018-01-0414
OAAI
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

英国男性HOXB13 G84E种系突变的患病率及其与前列腺癌风险,肿瘤特征和临床结局的相关性

2015-04-0182
OAAI